Development and Initial Validation of the Asthma Severity Scoring System (ASSESS).

[1]  M. Humbert,et al.  Clinical and economic burden of severe asthma: A French cohort study. , 2018, Respiratory medicine.

[2]  S. Szefler.  Asthma across the lifespan: Time for a paradigm shift. , 2018, The Journal of allergy and clinical immunology.

[3]  E. Bleecker,et al.  Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age. , 2017, Journal of Allergy and Clinical Immunology: In Practice.

[4]  E. Israel,et al.  Severe and Difficult‐to‐Treat Asthma in Adults , 2017, The New England journal of medicine.

[5]  S. Chhatre,et al.  Minimal important difference to infer changes in health-related quality of life-a systematic review. , 2017, Journal of Clinical Epidemiology.

[6]  J. Sastre,et al.  Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate–severe asthma , 2017, BMJ Open Respiratory Research.

[7]  A. Menzies-Gow,et al.  Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores , 2017, npj Primary Care Respiratory Medicine.

[8]  L. Heaney,et al.  The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis , 2017, Respiratory Research.

[9]  E. Bleecker,et al.  Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma , 2017, American journal of respiratory and critical care medicine.

[10]  G. Canonica,et al.  Asthma management in a specialist setting: Results of an Italian Respiratory Society survey. , 2017, Pulmonary pharmacology & therapeutics.

[11]  J. Muris,et al.  The contribution of an asthma diagnostic consultation service in obtaining an accurate asthma diagnosis for primary care patients: results of a real-life study , 2017, npj Primary Care Respiratory Medicine.

[12]  D. Jarvis,et al.  Assessment of asthma severity in adults with ever asthma: A continuous score , 2017, PloS one.

[13]  T. Casale,et al.  Biologic and New Therapies in Asthma. , 2017, Immunology and allergy clinics of North America.

[14]  A. Giardino,et al.  Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program , 2017, Pediatrics.

[15]  A. Fitzpatrick,et al.  Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features. , 2017, The journal of allergy and clinical immunology. In practice.

[16]  P. Gergen,et al.  Minimally important differences and risk levels for the Composite Asthma Severity Index. , 2017, The Journal of allergy and clinical immunology.

[17]  E. Bleecker,et al.  Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations , 2016, American journal of respiratory and critical care medicine.

[18]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal of chiropractic medicine.

[19]  J. Martin,et al.  Phenotyping of difficult asthma using longitudinal physiological and biomarker measurements reveals significant differences in stability between clusters , 2016, BMC Pulmonary Medicine.

[20]  C. Porsbjerg,et al.  Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study , 2016, Respiratory Research.

[21]  B. Cooper,et al.  Improved criterion for assessing lung function reversibility. , 2015, Chest.

[22]  Jonathan D. Campbell,et al.  Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  J. Swann,et al.  The effect of geographic access on severe health outcomes for pediatric asthma. , 2015, The Journal of allergy and clinical immunology.

[24]  Jonathan D. Campbell,et al.  Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.

[25]  D. Shaw,et al.  Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma. , 2014, The journal of allergy and clinical immunology. In practice.

[26]  P. Burton,et al.  Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability , 2014, PloS one.

[27]  G. Rust,et al.  Geographic and racial variation in asthma prevalence and emergency department use among Medicaid-enrolled children in 14 southern states , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.

[28]  C. Patterson,et al.  Inappropriate prescribing of combination inhalers in Northern Ireland: retrospective cross-sectional cohort study of prescribing practice in primary care , 2014, Primary care respiratory journal : journal of the General Practice Airways Group.

[29]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[30]  I. Urrutia,et al.  Asthma control and concordance of opinions between patients and pulmonologists , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

[31]  C. Sorkness,et al.  Daily diaries vs retrospective questionnaires to assess asthma control and therapeutic responses in asthma clinical trials: is participant burden worth the effort? , 2013, Chest.

[32]  P. Gergen,et al.  Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents. , 2012, Journal of Allergy and Clinical Immunology.

[33]  H. Boushey,et al.  Asthma outcomes: exacerbations. , 2012, The Journal of allergy and clinical immunology.

[34]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[35]  Mark Kosinski,et al.  The minimally important difference of the Asthma Control Test. , 2009, The Journal of allergy and clinical immunology.

[36]  I. Pavord,et al.  A new perspective on concepts of asthma severity and control , 2008, European Respiratory Journal.

[37]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[38]  Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. , 2007, The Journal of allergy and clinical immunology.

[39]  Martin Brunner,et al.  Analyzing the Reliability of Multidimensional Measures: An Example from Intelligence Research , 2005 .

[40]  E. Juniper,et al.  Clinicians tend to overestimate improvements in asthma control: an unexpected observation. , 2004, Primary care respiratory journal : journal of the General Practice Airways Group.

[41]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[42]  G. Guyatt,et al.  Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life , 2001, Medical care.

[43]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[44]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[45]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[46]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[47]  D. Postma,et al.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. , 1992, Thorax.